Paving the way to better care
A public-private international research collaboration aiming to personalise prevention and treatment of cardiovascular disease.
The challenge of cardiovascular disease
Cardiovascular disease (CVD) is the most common cause of death worldwide and has an incredibly large impact on people’s lives and wellbeing. The combination of an ageing population, unhealthy lifestyle, and increased numbers of risk factors, like hypertension, dyslipidemia, diabetes, and chronic kidney disease has led to a rise in the number of patients with CVD, reaching over 85 million in Europe alone.
Despite scientific advancements, the combination of risk factors linked to CVD and the presence of co-morbidities have made treatment difficult, making it urgent to address the complexity of CVD.
Number of people affected by CVD
> 500 million worldwide
Number of people that die from CVD
~ 17 million worldwide
iCARE4CVD is an international, public-private research project that brings together 33 academic and industry partners united in the pursuit of improving the health of patients with CVD. The project will run for 4.5 years, led by University of Maastricht and Novo Nordisk.
iCARE4CVD aims to improve four key areas of current CVD healthcare by:
The project will achieve this by:
iCARE4CVD brings together 33 leading international partners from civil society, academia and industry, and is lead by Maastricht University and global
healthcare company Novo Nordisk.
Have any questions? Send us a message.
Feel free to reach out to us using the form below. We value your feedback, questions, and any inquiries you might have. Our team is here to assist you and will respond as soon as possible. We look forward to hearing from you and starting a meaningful conversation.
Stay In the loop:
Subscribe to our newsletter
Subscribe to our newsletter to stay up to date with all the most recent information about iCARE4CVD.